TG THERAPEUTICS, INC. (TGTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 90M 180M 270M Q1 '17: 38K Q2 '17: 38K Q3 '17: 38K Q4 '17: 38K Q1 '18: 38K Q2 '18: 38K Q3 '18: 38K Q4 '18: 38K Q1 '19: 38K Q2 '19: 38K Q3 '19: 38K Q4 '19: 38K Q1 '20: 38K Q2 '20: 38K Q3 '20: 38K Q4 '20: 38K Q1 '21: 793K Q2 '21: 1.5M Q3 '21: 2M Q4 '21: 2.3M Q1 '22: 2M Q2 '22: 594K Q3 '22: 94K Q4 '22: 80K Q1 '23: 7.8M Q2 '23: 16.1M Q3 '23: 165.8M Q4 '23: 44M Q1 '24: 63.5M Q2 '24: 73.5M Q3 '24: 83.9M Q4 '24: 108.2M Q1 '25: 120.9M Q2 '25: 141.1M Q3 '25: 161.7M Q4 '25: 192.6M Q1 '26: 204.9M Q2 '26: 240.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 70M 140M 210M Q3 '22: 92K Q4 '22: 77K Q1 '23: 6.9M Q2 '23: 14.2M Q3 '23: 162.3M Q4 '23: 36.1M Q1 '24: 58M Q2 '24: 65.2M Q3 '24: 74.5M Q4 '24: 92.8M Q1 '25: 105.3M Q2 '25: 122.2M Q3 '25: 133.6M Q4 '25: 154.4M Q1 '26: 171.4M Q2 '26: 199.1M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q2 '10: -525.1K Q3 '10: -515.6K Q1 '11: 0 Q2 '11: -297K Q3 '11: -30.1K Q4 '11: -554.9K Q1 '12: -17.4M Q2 '12: -3.1M Q3 '12: -2.7M Q4 '12: -3.7M Q1 '13: -3.7M Q2 '13: -6.6M Q3 '13: -4.6M Q4 '13: -8M Q1 '14: -7.6M Q2 '14: -12M Q3 '14: -17.4M Q4 '14: -18.7M Q1 '15: -14.6M Q2 '15: -17.1M Q3 '15: -13.8M Q4 '15: -17.6M Q1 '16: -14M Q2 '16: -16M Q3 '16: -24.9M Q4 '16: -24M Q1 '17: -27.7M Q2 '17: -28.4M Q3 '17: -31.6M Q4 '17: -31M Q1 '18: -41.6M Q2 '18: 44.3M Q3 '18: -34.3M Q4 '18: -54.1M Q1 '19: -34.7M Q2 '19: -35.5M Q3 '19: -60.9M Q4 '19: -38M Q1 '20: -50.2M Q2 '20: -50.8M Q3 '20: -85.7M Q4 '20: -86.8M Q1 '21: -89.2M Q2 '21: -77.5M Q3 '21: -85.1M Q4 '21: -92.9M Q1 '22: -66.9M Q2 '22: -38.9M Q3 '22: -35M Q4 '22: -77.5M Q1 '23: -37M Q2 '23: -44.7M Q3 '23: 114.8M Q4 '23: -12.5M Q1 '24: -9.3M Q2 '24: 8.8M Q3 '24: 12.4M Q4 '24: 29.9M Q1 '25: 8.6M Q2 '25: 34.8M Q3 '25: 29.4M Q4 '25: 50.5M Q1 '26: 34.8M Q2 '26: 21.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-150M 0 150M 300M 450M Q2 '10: 1.9M Q3 '10: 41.2K Q4 '10: 365.2K Q1 '11: 0 Q2 '11: -282.1K Q3 '11: -28.6K Q4 '11: -542.4K Q1 '12: -10.3M Q2 '12: -1.9M Q3 '12: -2.5M Q4 '12: -3.5M Q1 '13: -3.7M Q2 '13: -6.6M Q3 '13: -4.6M Q4 '13: -5.7M Q1 '14: -7.5M Q2 '14: -12M Q3 '14: -17.5M Q4 '14: -18.8M Q1 '15: -14.6M Q2 '15: -17.1M Q3 '15: -13.7M Q4 '15: -17.6M Q1 '16: -13.8M Q2 '16: -15.9M Q3 '16: -24.8M Q4 '16: -23.7M Q1 '17: -27.7M Q2 '17: -28.4M Q3 '17: -31.5M Q4 '17: -30.9M Q1 '18: -41.5M Q2 '18: -44.1M Q3 '18: -34M Q4 '18: -53.9M Q1 '19: -35.2M Q2 '19: -36.2M Q3 '19: -61.9M Q4 '19: -39.6M Q1 '20: -51.1M Q2 '20: -52.9M Q3 '20: -87.2M Q4 '20: -88.2M Q1 '21: -90.6M Q2 '21: -78.5M Q3 '21: -85.6M Q4 '21: -93.3M Q1 '22: -69M Q2 '22: -40.5M Q3 '22: -35.8M Q4 '22: -78.5M Q1 '23: -39.2M Q2 '23: -47.6M Q3 '23: 113.9M Q4 '23: -14.4M Q1 '24: -10.7M Q2 '24: 6.9M Q3 '24: 3.9M Q4 '24: 23.3M Q1 '25: 5.1M Q2 '25: 28.2M Q3 '25: 390.9M Q4 '25: 23M Q1 '26: 19.8M Q2 '26: 7.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 15M 30M 45M Q1 '21: 139K Q3 '22: 2K Q4 '22: 3K Q1 '23: 857K Q2 '23: 1.9M Q3 '23: 3.5M Q4 '23: 7.9M Q1 '24: 5.4M Q2 '24: 8.3M Q3 '24: 9.3M Q4 '24: 15.4M Q1 '25: 15.5M Q2 '25: 18.9M Q3 '25: 28.1M Q4 '25: 38.1M Q1 '26: 33.5M Q2 '26: 41.2M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-90M -60M -30M 0 30M 60M 90M Q3 '10: -412.7K Q3 '11: -30.1K Q4 '11: -56.5K Q1 '12: -861.6K Q2 '12: -499.8K Q3 '12: -3M Q4 '12: -833.3K Q1 '13: -2.2M Q2 '13: -2.6M Q3 '13: -1.2M Q4 '13: -4.8M Q1 '14: -8.3M Q2 '14: -3.6M Q3 '14: -8.1M Q4 '14: -15.1M Q1 '15: -8.9M Q2 '15: -12.2M Q3 '15: -10.7M Q4 '15: -12.9M Q1 '16: -16.7M Q2 '16: -12.9M Q3 '16: -15M Q4 '16: -17M Q1 '17: -22.3M Q2 '17: -26.8M Q3 '17: -22.8M Q4 '17: -21.9M Q1 '18: -28M Q2 '18: -34.2M Q3 '18: -33M Q4 '18: -33.7M Q1 '19: -33.4M Q2 '19: -35.9M Q3 '19: -33.2M Q4 '19: -30.4M Q1 '20: -62.1M Q2 '20: -43.8M Q3 '20: -56.5M Q4 '20: -52M Q1 '21: -81.4M Q2 '21: -60.2M Q3 '21: -67.2M Q4 '21: -86.9M Q1 '22: -68.7M Q2 '22: -49.1M Q3 '22: -34.5M Q4 '22: -23.9M Q1 '23: -59.9M Q2 '23: -42M Q3 '23: 83.7M Q4 '23: -13.2M Q1 '24: -8.2M Q2 '24: 5.5M Q3 '24: -12.2M Q4 '24: -25.6M Q1 '25: -28.7M Q2 '25: 7.4M Q3 '25: -23.2M Q4 '25: 19.7M Q1 '26: -17.9M Q2 '26: 39.3M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-90M -60M -30M 0 30M 60M 90M Q3 '10: -412.7K Q3 '11: -30.1K Q4 '11: -56.5K Q1 '12: -861.6K Q2 '12: -501.2K Q3 '12: -3M Q4 '12: -833.3K Q1 '13: -2.2M Q2 '13: -2.6M Q3 '13: -1.2M Q4 '13: -4.8M Q1 '14: -8.3M Q2 '14: -3.6M Q3 '14: -8.1M Q4 '14: -15.1M Q1 '15: -8.9M Q2 '15: -12.3M Q3 '15: -10.7M Q1 '16: -17M Q2 '16: -12.9M Q3 '16: -15.1M Q4 '16: -17M Q1 '17: -22.3M Q2 '17: -26.8M Q3 '17: -22.8M Q4 '17: -21.9M Q1 '18: -28.1M Q2 '18: -34.2M Q3 '18: -33M Q4 '18: -33.7M Q1 '19: -33.4M Q2 '19: -35.9M Q3 '19: -33.3M Q4 '19: -30.4M Q1 '20: -62.2M Q2 '20: -43.9M Q3 '20: -56.6M Q4 '20: -52.2M Q1 '21: -81.4M Q2 '21: -60.3M Q3 '21: -67.3M Q4 '21: -87M Q1 '22: -68.7M Q2 '22: -49.1M Q3 '22: -34.5M Q4 '22: -23.9M Q4 '23: -13.2M Q1 '24: -8.2M Q2 '24: 5.5M Q3 '24: -12.2M Q4 '24: -25.7M Q1 '25: -28.7M Q2 '25: 7.4M Q3 '25: -23.2M Q4 '25: 19.6M Q1 '26: -17.9M Q2 '26: 39M Q3 '10 Q2 '13 Q2 '15 Q3 '17 Q3 '19 Q3 '21 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '21: 131.9M Q2 '21: 132.1M Q3 '21: 132.4M Q1 '22: 134.4M Q2 '22: 134.8M Q3 '22: 135.3M Q1 '23: 140.3M Q2 '23: 141.5M Q3 '23: 155.9M Q1 '24: 146.2M Q2 '24: 159.4M Q3 '24: 160.7M Q1 '25: 162.8M Q2 '25: 162.6M Q3 '25: 161M Q1 '26: 160.1M Q2 '26: 157.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q4 '11: -0.44 Q1 '12: -2.42 Q2 '12: -2.43 Q3 '12: -2.58 Q4 '13: -0.81 Q1 '14: -0.89 Q2 '14: -0.96 Q3 '14: -1.31 Q4 '14: -1.60 Q1 '15: -1.70 Q2 '15: -1.72 Q3 '15: -1.49 Q4 '15: -1.38 Q1 '16: -1.31 Q2 '16: -1.26 Q3 '16: -1.48 Q4 '16: -1.59 Q1 '17: -1.83 Q2 '17: -1.95 Q3 '17: -1.93 Q4 '17: -1.91 Q1 '18: -1.98 Q2 '18: -0.94 Q3 '18: -0.89 Q4 '18: -1.11 Q1 '19: -0.95 Q2 '19: -1.96 Q3 '19: -2.22 Q4 '19: -1.98 Q1 '20: -2.03 Q2 '20: -2.08 Q3 '20: -2.12 Q4 '20: -2.40 Q1 '21: -2.61 Q2 '21: -2.73 Q3 '21: -2.65 Q4 '21: -2.63 Q1 '22: -2.45 Q2 '22: -2.16 Q3 '22: -1.77 Q4 '22: -1.64 Q1 '23: -1.41 Q2 '23: -1.45 Q3 '23: -0.46 Q4 '23: 0.09 Q1 '24: 0.30 Q2 '24: 0.68 Q3 '24: -0.03 Q4 '24: 0.14 Q1 '25: 0.24 Q2 '25: 0.37 Q3 '25: 2.78 Q4 '25: 2.78 Q1 '26: 2.87 Q2 '26: 2.75 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.